
Lagevrio Coupons & Savings Card – Discount Prices from $991.80
My prescription
Edit
200MG, Lagevrio (40 Capsules)
Select pharmacy

CVS
$1772.67
COUPON PRICE
Albertsons
$991.80
COUPON PRICE
Walgreens
$991.80
COUPON PRICE
Walmart
$993.60
COUPON PRICELagevrio savings card
Show this card to your pharmacist
Albertsons
$991.80
BIN
ID
PCN
GRP
011867
LH054FAE5C
HT
LABH001
Powered by
More prescriptions for covid-19
More prescriptions for covid-19
Price history for Lagevrio
40 Capsules, 200MG
Average retail price for Lagevrio
Average SaveHealth price for Lagevrio
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Lagevrio dosage forms
Dosage Quantity Price from Per unit 200MG 40 Capsules $1067.59 $26.69
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 200MG | 40 Capsules | $1067.59 | $26.69 |
What is the drug Lagevrio used for?
Lagevrio is used for the treatment of mild to moderate COVID-19 in adults who are at high risk for progressing to severe disease, including hospitalization or death.
Is lagevrio better than Paxlovid?
The effectiveness of Lagevrio (molnupiravir) versus Paxlovid (nirmatrelvir/ritonavir) can vary depending on individual patient circumstances, including the severity of the COVID-19 infection, underlying health conditions, and potential drug interactions. Paxlovid has generally shown higher efficacy in reducing the risk of hospitalization and death in clinical trials compared to Lagevrio. However, the choice between these medications should be made by a healthcare provider, who can consider the specific needs and medical history of the patient.
What is the downside of taking Lagevrio?
Lagevrio, also known as molnupiravir, may have several potential downsides or side effects. Common side effects include diarrhea, nausea, and dizziness. There is also a concern about its potential to cause mutations, which could theoretically lead to long-term effects, although this risk is still being studied. Additionally, it is not recommended for use during pregnancy due to potential risks to the fetus. As with any medication, it is important to discuss potential risks and benefits with a healthcare provider.
How effective is lagevrio in treating COVID?
Lagevrio (molnupiravir) has been shown to be effective in reducing the risk of hospitalization and death in patients with mild to moderate COVID-19 who are at high risk for severe disease. Clinical trials have demonstrated that it can decrease the likelihood of progression to severe illness when administered early in the course of the infection. However, its effectiveness may vary based on individual patient factors and the specific variant of the virus. It is important for patients to consult with their healthcare provider to determine if Lagevrio is an appropriate treatment option for their situation.
Who shouldn't take molnupiravir?
Molnupiravir should not be taken by individuals who are allergic to any of its components. It is also not recommended for use in pregnant women due to potential risks to the fetus. Additionally, it should be used with caution in breastfeeding women, and they should consult their healthcare provider before use. Molnupiravir is not authorized for use in patients under 18 years of age. It is important for individuals to discuss their medical history and current medications with their healthcare provider before starting molnupiravir.
